688073 毕得医药
交易中 08-14 14:39:39
资讯
新帖
简况
股市必读：毕得医药新发布《简式权益变动报告书》
证券之星 · 01:02
股市必读：毕得医药新发布《简式权益变动报告书》
8月13日毕得医药涨6.57%，大摩健康产业混合A基金重仓该股
证券之星 · 08-13 16:36
8月13日毕得医药涨6.57%，大摩健康产业混合A基金重仓该股
毕得医药收上交所监管工作函 中欧基金工银瑞信等持股
中金财经 · 08-13 16:00
毕得医药收上交所监管工作函 中欧基金工银瑞信等持股
8月12日毕得医药涨5.56%，大摩健康产业混合A基金重仓该股
证券之星 · 08-12 16:31
8月12日毕得医药涨5.56%，大摩健康产业混合A基金重仓该股
8月11日毕得医药发生2笔大宗交易 成交金额420.8万元
证券之星 · 08-11 17:40
8月11日毕得医药发生2笔大宗交易 成交金额420.8万元
8月10日毕得医药涨20.00%，大摩健康产业混合A基金重仓该股
证券之星 · 08-10
8月10日毕得医药涨20.00%，大摩健康产业混合A基金重仓该股
8月7日毕得医药（688073）龙虎榜数据：机构净买入3568.07万元，北向资金净买入569.35万元
证券之星 · 08-07
8月7日毕得医药（688073）龙虎榜数据：机构净买入3568.07万元，北向资金净买入569.35万元
8月7日毕得医药涨20.01%，大摩健康产业混合A基金重仓该股
证券之星 · 08-07
8月7日毕得医药涨20.01%，大摩健康产业混合A基金重仓该股
股市必读：毕得医药新发布《上海君澜律师事务所关于上海毕得医药科技股份有限公司相关股东终止一致行动协议之法律意见书》
证券之星 · 08-07
股市必读：毕得医药新发布《上海君澜律师事务所关于上海毕得医药科技股份有限公司相关股东终止一致行动协议之法律意见书》
毕得医药（688073）披露实际控制人一致行动协议到期不再续签暨实际控制人未发生变更的提示性公告，8月6日股价下跌0.21%
证券之星 · 08-06
毕得医药（688073）披露实际控制人一致行动协议到期不再续签暨实际控制人未发生变更的提示性公告，8月6日股价下跌0.21%
每周股票复盘：毕得医药（688073）发生1笔大宗交易成交245万元
证券之星 · 08-02
每周股票复盘：毕得医药（688073）发生1笔大宗交易成交245万元
毕得医药获得发明专利授权：“一种咪唑并哒嗪类化合物的合成方法”
证券之星 · 07-29
毕得医药获得发明专利授权：“一种咪唑并哒嗪类化合物的合成方法”
7月28日毕得医药发生1笔大宗交易 成交金额245万元
证券之星 · 07-28
7月28日毕得医药发生1笔大宗交易 成交金额245万元
每周股票复盘：毕得医药（688073）现折价22.35%大宗交易
证券之星 · 07-26
每周股票复盘：毕得医药（688073）现折价22.35%大宗交易
7月20日毕得医药现1笔折价22.35%的大宗交易 合计成交252.98万元
证券之星 · 07-20
7月20日毕得医药现1笔折价22.35%的大宗交易 合计成交252.98万元
每周股票复盘：毕得医药（688073）现大宗交易机构净买入521.17万元
证券之星 · 07-19
每周股票复盘：毕得医药（688073）现大宗交易机构净买入521.17万元
7月17日毕得医药跌15.11%，信澳信用债债券A基金重仓该股
证券之星 · 07-17
7月17日毕得医药跌15.11%，信澳信用债债券A基金重仓该股
7月16日毕得医药现3笔大宗交易 机构净买入521.17万元
证券之星 · 07-16
7月16日毕得医药现3笔大宗交易 机构净买入521.17万元
7月14日毕得医药涨6.72%，信澳信用债债券A基金重仓该股
证券之星 · 07-14
7月14日毕得医药涨6.72%，信澳信用债债券A基金重仓该股
每周股票复盘：机构连续两日净买入毕得医药（688073）
证券之星 · 07-12
每周股票复盘：机构连续两日净买入毕得医药（688073）
加载更多
公司概况
公司名称：
上海毕得医药科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2022-10-11
主营业务：
上海毕得医药科技股份有限公司的主营业务是药物分子砌块和科学试剂的研发、设计、生产及销售。公司的主要产品是分子砌块杂环化合物、分子砌块苯环化合物、分子砌块脂肪族类化合物、催化剂和配体、生命科学试剂。截至报告期末，公司知识产权项目获得授权数量148个，其中发明专利59个，实用新型专利24个，外观设计专利1个，软件著作权2个，其他62个。
发行价格：
88.00
{"stockData":{"symbol":"688073","market":"SH","secType":"STK","nameCN":"毕得医药","latestPrice":82.57,"timestamp":1786689579000,"preClose":84.83,"halted":0,"volume":7218137,"delay":0,"changeRate":-0.0266,"floatShares":90882900,"shares":90882900,"eps":1.8472,"marketStatus":"交易中","change":-2.26,"latestTime":"08-14 14:39:39","open":85.07,"high":85.6,"low":80.31,"amount":593000000,"amplitude":0.0624,"askPrice":82.57,"askSize":0,"bidPrice":82.55,"bidSize":5,"shortable":0,"etf":0,"ttmEps":1.8472,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1786690800000},"marketStatusCode":2,"adr":0,"adjPreClose":84.83,"symbolType":"stock_kcb","openAndCloseTimeList":[[1786671000000,1786678200000],[1786683600000,1786690800000]],"highLimit":93.31,"lowLimit":76.35,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":90882948,"isCdr":false,"pbRate":3.67,"roa":"--","peRate":44.700087,"roe":"2.26%","epsLYR":1.75,"committee":0.371429,"marketValue":7504000000,"turnoverRate":0.0794,"status":1,"floatMarketCap":7504000000},"requestUrl":"/m/hq/s/688073/","defaultTab":"news","newsList":[{"id":"2659169615","title":"股市必读：毕得医药新发布《简式权益变动报告书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2659169615","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659169615?lang=zh_cn&edition=full","pubTime":"2026-08-14 01:02","pubTimestamp":1786640539,"startTime":"0","endTime":"0","summary":"关于股东权益变动触及5%整数倍的提示性公告2026年1月28日至8月11日，舟山兰旦企业管理合伙企业、舟山欣曦企业管理合伙企业及吴波通过大宗交易和集中竞价方式合计减持毕得医药股份4,544,153股，占公司总股本的5.00%；减持后合计持股比例由10.00%减少至5.00%；权益变动未违反已披露承诺，不触发强制要约收购义务，不会导致公司控股股东、实际控制人发生变化；相关方已履行减持计划的信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400000747.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659270132","title":"8月13日毕得医药涨6.57%，大摩健康产业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2659270132","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659270132?lang=zh_cn&edition=full","pubTime":"2026-08-13 16:36","pubTimestamp":1786610171,"startTime":"0","endTime":"0","summary":"证券之星消息，8月13日毕得医药涨6.57%创60日新高，收盘报84.83元，换手率10.51%，成交量9.55万手，成交额7.99亿元。重仓毕得医药的公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共8家，其中持有数量最多的公募基金为摩根士丹利基金的大摩健康产业混合A。大摩健康产业混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300026840.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659134053","title":"毕得医药收上交所监管工作函 中欧基金工银瑞信等持股","url":"https://stock-news.laohu8.com/highlight/detail?id=2659134053","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659134053?lang=zh_cn&edition=full","pubTime":"2026-08-13 16:00","pubTimestamp":1786608006,"startTime":"0","endTime":"0","summary":"中国经济网北京8月13日讯 上交所网站昨日更新公告显示，毕得医药 于8月12日收到关于上海毕得医药科技股份有限公司相关事项的监管工作函。 公告显示，此次监管工作函的监管类型为“监管工作函”，涉及对象包括上市公司本身、公司董事、高级管理人员以及控股股东及实际控制人，处理事由为“关于上海毕得医药科技股份有限公司相关事项的监管工作函”，但未披露具体涉及的相关事项细节。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202608/13/20260813339021.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202608/13/20260813339021.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260813/32333933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["688073","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658920390","title":"8月12日毕得医药涨5.56%，大摩健康产业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2658920390","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658920390?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:31","pubTimestamp":1786523515,"startTime":"0","endTime":"0","summary":"证券之星消息，8月12日毕得医药涨5.56%创60日新高，收盘报79.6元，换手率9.42%，成交量8.56万手，成交额6.7亿元。重仓毕得医药的公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共8家，其中持有数量最多的公募基金为摩根士丹利基金的大摩健康产业混合A。大摩健康产业混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200027604.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688073"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658592999","title":"8月11日毕得医药发生2笔大宗交易 成交金额420.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658592999","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658592999?lang=zh_cn&edition=full","pubTime":"2026-08-11 17:40","pubTimestamp":1786441254,"startTime":"0","endTime":"0","summary":"证券之星消息，8月11日毕得医药发生大宗交易，交易数据如下：近三个月该股共发生22笔大宗交易，合计成交1.29万手，折价成交21笔，溢价成交1笔。该股在过去半年内已有共计4764.88万股限售解禁股上市，占公司总股本的52.43%。截至2026年8月11日收盘，毕得医药(688073)报收于75.41元，上涨2.02%，换手率10.99%，成交量9.99万手，成交额7.37亿元。该股近半年内有股东持股变动，合计净减持308.35万股，股东增减持明细如下表：该股最近90天内共有2家机构给出评级，买入评级2家。本文数据来源于上海证券交易所大宗交易信息披露，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100028678.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688073"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658998922","title":"8月10日毕得医药涨20.00%，大摩健康产业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2658998922","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658998922?lang=zh_cn&edition=full","pubTime":"2026-08-10 16:37","pubTimestamp":1786351047,"startTime":"0","endTime":"0","summary":"证券之星消息，8月10日毕得医药涨20.00%创60日新高，收盘报73.92元，换手率11.62%，成交量10.56万手，成交额7.61亿元。重仓毕得医药的公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级3家。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共8家，其中持有数量最多的公募基金为摩根士丹利基金的大摩健康产业混合A。大摩健康产业混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000020555.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657161482","title":"8月7日毕得医药（688073）龙虎榜数据：机构净买入3568.07万元，北向资金净买入569.35万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2657161482","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657161482?lang=zh_cn&edition=full","pubTime":"2026-08-07 17:45","pubTimestamp":1786095943,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年8月7日公布的交易公开信息显示，毕得医药因有价格涨跌幅限制的日收盘价格涨幅达到15%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年8月7日收盘，毕得医药报收于61.6元，上涨20.01%，涨停，换手率6.12%，成交量5.56万手，成交额3.23亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入3568.07万元，北向资金合计净买入569.35万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700030624.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657616552","title":"8月7日毕得医药涨20.01%，大摩健康产业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2657616552","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657616552?lang=zh_cn&edition=full","pubTime":"2026-08-07 16:39","pubTimestamp":1786091964,"startTime":"0","endTime":"0","summary":"证券之星消息，8月7日毕得医药涨20.01%创60日新高，收盘报61.6元，换手率6.12%，成交量5.56万手，成交额3.23亿元。重仓毕得医药的公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级3家。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共8家，其中持有数量最多的公募基金为摩根士丹利基金的大摩健康产业混合A。大摩健康产业混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700027960.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657511336","title":"股市必读：毕得医药新发布《上海君澜律师事务所关于上海毕得医药科技股份有限公司相关股东终止一致行动协议之法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657511336","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657511336?lang=zh_cn&edition=full","pubTime":"2026-08-07 02:12","pubTimestamp":1786039934,"startTime":"0","endTime":"0","summary":"公司公告汇总上海君澜律师事务所关于上海毕得医药科技股份有限公司相关股东终止一致行动协议之法律意见书上海毕得医药科技股份有限公司实际控制人戴岚与戴龙于2021年8月5日签署的《一致行动协议》于2026年8月5日到期终止，戴龙先生提出不再续展。协议终止后，双方仍为一致行动人，股份合并计算，公司控股股东、实际控制人未发生变更。本次协议终止不涉及权益变动，不影响公司治理结构和持续经营。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700001989.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657390658","title":"毕得医药（688073）披露实际控制人一致行动协议到期不再续签暨实际控制人未发生变更的提示性公告，8月6日股价下跌0.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657390658","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657390658?lang=zh_cn&edition=full","pubTime":"2026-08-06 22:39","pubTimestamp":1786027155,"startTime":"0","endTime":"0","summary":"截至2026年8月6日收盘，毕得医药报收于51.33元，较前一交易日下跌0.21%，最新总市值为46.65亿元。该股当日开盘51.03元，最高52.57元，最低50.52元，成交额达9050.46万元，换手率为1.93%。近日，毕得医药发布《关于实际控制人一致行动协议到期不再续签暨实际控制人未发生变更的提示性公告》。公告显示，公司实际控制人戴岚与戴龙签署的《一致行动协议》已到期终止，不再续签。本次协议终止不涉及权益变动，不影响公司治理结构和持续经营。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600040115.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688073"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656196623","title":"每周股票复盘：毕得医药（688073）发生1笔大宗交易成交245万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2656196623","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656196623?lang=zh_cn&edition=full","pubTime":"2026-08-02 03:15","pubTimestamp":1785611714,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘，毕得医药（688073）报收于47.23元，较上周的47.07元上涨0.34%。本周，毕得医药7月27日盘中最高价报50.0元。7月30日盘中最低价报44.46元。毕得医药当前最新总市值42.92亿元，在医疗服务板块市值排名34/51，在两市A股市值排名3341/5202。本周关注点来自交易信息汇总：7月28日毕得医药发生1笔大宗交易，成交金额245万元交易信息汇总7月28日毕得医药发生1笔大宗交易，成交金额245万元以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080200001026.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688073"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655882753","title":"毕得医药获得发明专利授权：“一种咪唑并哒嗪类化合物的合成方法”","url":"https://stock-news.laohu8.com/highlight/detail?id=2655882753","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655882753?lang=zh_cn&edition=full","pubTime":"2026-07-29 03:34","pubTimestamp":1785267296,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示毕得医药新获得一项发明专利授权，专利名为“一种咪唑并哒嗪类化合物的合成方法”，专利申请号为CN202311869245.3，授权日为2026年7月28日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900003742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654008923","title":"7月28日毕得医药发生1笔大宗交易 成交金额245万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2654008923","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654008923?lang=zh_cn&edition=full","pubTime":"2026-07-28 17:52","pubTimestamp":1785232340,"startTime":"0","endTime":"0","summary":"证券之星消息，7月28日毕得医药发生大宗交易，交易数据如下：大宗交易成交价格49元，相对当日收盘价溢价4.95%，成交5万股，成交金额245万元，买方营业部为东方证券股份有限公司浙江分公司，卖方营业部为浙商证券股份有限公司上海长乐路证券营业部。近三个月该股共发生20笔大宗交易，合计成交1.23万手，折价成交19笔，溢价成交1笔。截至2026年7月28日收盘，毕得医药报收于46.69元，下跌3.89%，换手率1.79%，成交量1.62万手，成交额7674.33万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800029303.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688073"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654057872","title":"每周股票复盘：毕得医药（688073）现折价22.35%大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2654057872","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654057872?lang=zh_cn&edition=full","pubTime":"2026-07-26 02:05","pubTimestamp":1785002713,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，毕得医药报收于47.07元，较上周的48.65元下跌3.25%。本周，毕得医药7月22日盘中最高价报52.49元。7月21日盘中最低价报46.03元。毕得医药当前最新总市值42.78亿元，在医疗服务板块市值排名35/51，在两市A股市值排名3242/5200。交易信息汇总7月20日毕得医药现1笔折价22.35%的大宗交易，合计成交252.98万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072600000533.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652294362","title":"7月20日毕得医药现1笔折价22.35%的大宗交易 合计成交252.98万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2652294362","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652294362?lang=zh_cn&edition=full","pubTime":"2026-07-20 17:48","pubTimestamp":1784540898,"startTime":"0","endTime":"0","summary":"证券之星消息，7月20日毕得医药发生大宗交易，交易数据如下：大宗交易成交价格38.92元，相对当日收盘价折价22.35%，成交6.5万股，成交金额252.98万元，买方营业部为中信建投证券股份有限公司北京鸿翼分公司，卖方营业部为浙商证券股份有限公司上海长乐路证券营业部。近三个月该股共发生26笔大宗交易，合计成交1.6万手，折价成交26笔。截至2026年7月20日收盘，毕得医药报收于50.12元，上涨3.02%，换手率3.8%，成交量3.45万手，成交额1.72亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000027655.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652237711","title":"每周股票复盘：毕得医药（688073）现大宗交易机构净买入521.17万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2652237711","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652237711?lang=zh_cn&edition=full","pubTime":"2026-07-19 01:55","pubTimestamp":1784397311,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，毕得医药报收于48.65元，较上周的53.05元下跌8.29%。本周，毕得医药7月15日盘中最高价报60.6元。上海毕得医药科技股份有限公司于2026年7月16日召开2026年第二次临时股东会，会议由董事长戴岚主持，采用现场与网络投票结合方式召开，出席会议股东共54人，代表有表决权股份30,845,747股，占公司总表决权数的35.8035%。北京国枫律师事务所对本次会议出具法律意见书，认为会议召集、召开程序及表决结果合法有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900000460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688073"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652595405","title":"7月17日毕得医药跌15.11%，信澳信用债债券A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652595405","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652595405?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:20","pubTimestamp":1784276448,"startTime":"0","endTime":"0","summary":"证券之星消息，7月17日毕得医药跌15.11%，收盘报48.65元，换手率6.2%，成交量5.63万手，成交额2.9亿元。重仓毕得医药的公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级3家。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共8家，其中持有数量最多的公募基金为信达澳亚基金的信澳信用债债券A。信澳信用债债券A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700029674.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","159397","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651641004","title":"7月16日毕得医药现3笔大宗交易 机构净买入521.17万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651641004","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651641004?lang=zh_cn&edition=full","pubTime":"2026-07-16 17:27","pubTimestamp":1784194079,"startTime":"0","endTime":"0","summary":"证券之星消息，7月16日毕得医药发生大宗交易，交易数据如下：近三个月该股共发生29笔大宗交易，合计成交1.71万手，折价成交29笔。该股在过去半年内已有共计4764.88万股限售解禁股上市，占公司总股本的52.43%。截至2026年7月16日收盘，毕得医药(688073)报收于57.31元，下跌0.21%，换手率5.35%，成交量4.87万手，成交额2.79亿元。该股近半年内有股东持股变动，合计净减持308.35万股，股东增减持明细如下表：该股最近90天内共有3家机构给出评级，买入评级3家。本文数据来源于上海证券交易所大宗交易信息披露，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600028592.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651417344","title":"7月14日毕得医药涨6.72%，信澳信用债债券A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651417344","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651417344?lang=zh_cn&edition=full","pubTime":"2026-07-14 16:19","pubTimestamp":1784017140,"startTime":"0","endTime":"0","summary":"证券之星消息，7月14日毕得医药涨6.72%，收盘报54.95元，换手率4.8%，成交量4.37万手，成交额2.32亿元。重仓毕得医药的公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级3家。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共8家，其中持有数量最多的公募基金为信达澳亚基金的信澳信用债债券A。信澳信用债债券A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400030364.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216","159397"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650154845","title":"每周股票复盘：机构连续两日净买入毕得医药（688073）","url":"https://stock-news.laohu8.com/highlight/detail?id=2650154845","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650154845?lang=zh_cn&edition=full","pubTime":"2026-07-12 01:55","pubTimestamp":1783792512,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，毕得医药报收于53.05元，较上周的54.51元下跌2.68%。本周关注点来自交易信息汇总：7月6日与7日毕得医药共发生8笔大宗交易，机构合计净买入1402.07万元。7月6日毕得医药发生4笔大宗交易，机构净买入895.27万元。股本股东变化股东增减持7月8日毕得医药发布公告，股东舟山欣曦企业管理合伙企业、舟山兰旦企业管理合伙企业于2026年6月29日至7月7日期间合计减持118.49万股，占公司总股本的1.3037%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071200000501.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786689582375,"stockEarnings":[{"period":"1week","weight":0.6526},{"period":"1month","weight":0.5438},{"period":"3month","weight":0.5722},{"period":"6month","weight":0.4546},{"period":"1year","weight":0.4736},{"period":"ytd","weight":0.4229}],"compareEarnings":[{"period":"1week","weight":0.0068},{"period":"1month","weight":-0.0101},{"period":"3month","weight":-0.0504},{"period":"6month","weight":-0.038},{"period":"1year","weight":0.0661},{"period":"ytd","weight":-0.0106}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海毕得医药科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"4924人(较上一季度增加26.52%)","perCapita":"18457股","listingDate":"2022-10-11","address":"上海市杨浦区翔殷路128号11号楼A座101室","registeredCapital":"9088万元","survey":" 上海毕得医药科技股份有限公司的主营业务是药物分子砌块和科学试剂的研发、设计、生产及销售。公司的主要产品是分子砌块杂环化合物、分子砌块苯环化合物、分子砌块脂肪族类化合物、催化剂和配体、生命科学试剂。截至报告期末，公司知识产权项目获得授权数量148个，其中发明专利59个，实用新型专利24个，外观设计专利1个，软件著作权2个，其他62个。","listedPrice":88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"毕得医药(688073)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供毕得医药(688073)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"毕得医药,688073,毕得医药股票,毕得医药股票老虎,毕得医药股票老虎国际,毕得医药行情,毕得医药股票行情,毕得医药股价,毕得医药股市,毕得医药股票价格,毕得医药股票交易,毕得医药股票购买,毕得医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"毕得医药(688073)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供毕得医药(688073)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}